Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Tohru Noguchi"'
Autor:
Kunimasa Yagi, Satoko Okazaki, Azusa Ohbatake, Masako Nakaya, Jianhui Liu, Eiko Arite, Yukiko Miyamoto, Naoko Ito, Kaoru Nakano, Naoto Yamaaki, Hisae Honoki, Shiho Fujisaka, Daisuke Chujo, Shinichiro Tsunoda, Kunio Yanagimoto, Tsuyoshi Nozue, Masayo Yamada, Kotaro Ooe, Tsutomu Araki, Akikatsu Nakashima, Yasushi Azami, Yukio Sodemoto, Kenichi Tadokoro, Makoto Nagano, Tohru Noguchi, Atsushi Nohara, Hideki Origasa, Yo Niida, Hayato Tada
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18889e852f170a17f3d98ebd5754c6ab
https://doi.org/10.2139/ssrn.4438312
https://doi.org/10.2139/ssrn.4438312
Autor:
TOHRU NOGUCHI
Publikováno v:
ENGLISH LINGUISTICS. 36:81-92
Autor:
Masa-aki Kawashiri, Takamitsu Nakano, Tetsuo Konno, Masakazu Yamagishi, Junji Kobayashi, Kenshi Hayashi, Chiaki Nakanishi, Hiroshi Mabuchi, Katsuyuki Nakajima, Akira Tanaka, Atsushi Nohara, Hayato Tada, Tohru Noguchi, Takeshi Inoue, Akihiro Inazu
Publikováno v:
European Journal of Clinical Investigation. 42:1094-1099
Eur J Clin Invest 2012; 42 (10): 1094–1099 Abstract Background Phenotype of autosomal recessive hypercholesterolaemia (ARH), a rare lipid disorder, is known to be milder than that of homozygous familial hypercholesterolaemia (FH) with LDL receptor
Autor:
Noboru Fujino, Kenshi Hayashi, Tetsuo Konno, Masakazu Yamagishi, Hiroshi Mabuchi, Junji Kobayashi, Chiaki Nakanishi, Atsushi Nohara, Akihiro Inazu, Masa-aki Kawashiri, Hayato Tada, Tohru Noguchi, Mika Mori
Publikováno v:
The American Journal of Cardiology. 109:364-369
Aggressive low-density lipoprotein (LDL) cholesterol-lowering therapy is important for high-risk patients. However, sparse data exist on the impact of combined aggressive LDL cholesterol-lowering therapy in familial hypercholesterolemia (FH), particu
Autor:
Masa-aki Kawashiri, Junji Kobayashi, Hiroshi Mabuchi, Atsushi Nohara, Tetsuo Konno, Masakazu Yamagishi, Kenshi Hayashi, Chiaki Nakanishi, Akihiro Inazu, Tohru Noguchi, Hayato Tada, Rumiko Ohtani
Publikováno v:
Atherosclerosis. 219:663-666
Background: Autosomal recessive hypercholesterolemia (ARH) is an extremely rare inherited hypercholesterolemia, the cause of which is mutations in low-density lipoprotein (LDL) receptor adaptor protein 1 (LDLRAP1) gene. Methods: A total of 146 hetero
Autor:
Junji Kobayashi, Hayato Tada, Akihiro Inazu, Masa-aki Kawashiri, Masakazu Yamagishi, Hiroshi Mabuchi, Chiaki Nakanishi, Tohru Noguchi, Atsushi Nohara
Publikováno v:
Clinica Chimica Acta. 412:1068-1075
Background We elucidated the difference between the effects of bezafibrate and atorvastatin in hypertriglyceridemia with apoE2/2 and 3/3. Methods An open randomized crossover study consisted of a 4-week treatment period with bezafibrate (400 mg daily
Autor:
Shinya Makino, Tohru Noguchi, Reiko Matsumoto, Shuichi Nakayama, Kozo Hashimoto, Mitsuru Nishiyama, Yoshio Terada
Publikováno v:
Endocrinology. 151:4344-4355
We have previously reported reduced glucocorticoid receptor (GR) mRNA levels in the hippocampus and hypothalamic paraventricular nucleus (PVN) during repeated immobilization, which is potentially associated with persistent activation of the hypothala
Publikováno v:
International Journal of Cast Metals Research. 21:219-225
State of technologies in Japan related to composite casting was reviewed based on the three year survey of Composite Casting Process Sub-Committee in Committee on Foundry Technology (24th) of JSPS. Other than making metal matrix composite, cast-in in
Isolation and gene analysis of interferon α-resistant cell clones of the hepatitis C virus subgenome
Publikováno v:
Virology. 375:424-432
Hepatitis C virus (HCV) proteins appear to play an important role in IFN-resistance, but the molecular mechanism remains unclear. To clarify the mechanism in HCV replicon RNA harboring Huh-7 cells (Huh-9-13), we isolated cellular clones with impaired
Publikováno v:
Neuroendocrinology. 86:1-16
In an attempt to clarify the role of the type 2 corticotropin-releasing hormone (CRH) receptor (CRHR-2) in the brain in activation of the hypothalamic-pituitary-adrenocortical axis, we conducted experiments using male Wistar rats. First, an injection